Individual and Environmental Factors Associated With Polypsychotropic Medication Regimens Among Adults With Intellectual Disability.

Fradet et al. (2025) looked at Oklahoma adults with intellectual disability who use HCBS waiver services.

They counted how many people take two or more psych meds at once.

Then they hunted for personal and environmental traits that go with heavy med use.

Polypsychotropic regimens are common in this group.

Certain individual and environmental factors line up with higher med counts.

The paper lists which traits raise the odds, giving clinicians a quick screen.

Martin et al. (1997) first mapped high chronic-disease load in Dutch residential adults with ID. L et al. extend that lens to 2025 U.S. community waiver clients, showing polypharmacy is the new face of that burden.

Amaral et al. (2019) found that polypharmacy predicts ER visits in the same population. L et al. now show which clients are most likely to be on those risky combos, linking the two papers into a care-planning pipeline.

Patton et al. (2020) proved adults with ID face 28 % higher odds of med-related hospitalization. L et al. supply the prevalence data that help you spot who sits in that danger zone before harm occurs.

You now have a short checklist of traits that flag heavy psych med use. Run this screen during intake or annual reviews. If several factors are present, schedule a med check and coordinate with psychiatry to taper or monitor. This simple step can cut side effects, ER trips, and hospital stays.